Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History (2 total)
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
1-2 of 2 transactions
About Casale Donn
Casale Donn (SEC CIK 0002135296) files insider reports with the SEC as President and CEO of ARS Pharmaceuticals, Inc. (SPRY).
Signal8 holds 3 ownership filings by Casale Donn (1 Form 3, 2 Form 4), filed between Jun 1, 2026 and Oct 5, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Casale Donn's filings is in SAN DIEGO, CA.
Recent filings by Casale Donn
Other insiders filing for ARS Pharmaceuticals, Inc. (SPRY)
- Smith Margaret Ekins, Chief Commercial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Dadoo Rajeev, Director
- Shah Pratik, Director
- Kelly Michael, Director
- Islam Saqib, Director